THE AUSTRIAN CENTRE
OF INDUSTRIAL BIOTECHNOLOGY

acib is an international competence centre, developing new, environmentally friendly, economically and technically advanced processes for the biotechnological, pharmaceutical and chemical industry – all of them modelled on nature. acib is bridging the gap between academic research and producing industry. The big advantage for acib partner organisations is the possibility to translate scientific results into concrete processes and product by using scientific know-how, academic infrastructure or industrial networks. Our platform offers tailor-made solutions for our stakeholders from Academia, Industry and Investors.

 LATEST BLOG ARTICLES

  • Internationaler Tag der Frauen und Mädchen in der Wissenschaft
  • Scientific Networking – Where are you traveling? … and why?
  • Semi-automation of process analytics – the “dish washer” of a bioprocessing lab
  • Recycling of protective suits
  • The Lump Sum Pilot – virtue or curse?
  • When biotechnologists follow their noses
  • How microbiome studies can provide the basis to reduce food waste
  • The orchestra of yeast and its fragrance show
  • Carbon dioxide in a circular economy
  • Time for real-time monitoring of biopharma production
  • Internationaler Tag der Frauen und Mädchen in der Wissenschaft

    Frauen und Mädchen in der Wissenschaft stellen in vielen Ländern der Welt eine soziologische ,,Rarität‘‘ dar. Dieses gesellschaftliche Phänomen wurde in den letzten Jahren weltweit immer öfter in den Fokus diverser Geschlechterstudien gestellt. Viele von diesen Studien tragen in erster Linie zu einer statistischen Definition dieses Phänomens bei. Dadurch wird das geschlechtliche Präsenzungleichgewicht in der Wissenschaft zunehmend als ein gesellschaftliches Problem erkannt. Auf der Suche nach der Erklärung der bereits mehrere Jahrhunderte lang existierenden Dominanz der Männer in der Wissenschaft werden auch Vergleiche zwischen den Ländern und Regionen der Welt gezogen.

    Read more

  • Scientific Networking – Where are you traveling? … and why?

    That special day I have got an email about open positions in Barcelona within H2020-MSCA-RISE acib project NEOSETAC. MSCA-RISE … I have seen this abbreviation many times before, written on diverse scientific publications, but I have never asked myself about the meaning. So finally, I have asked Google and I found the almost 70 pages counting ‘’Guide for Applicants’’ for Marie Skłodowska-Curie Actions Research and Innovation Staff Exchange program (MSCA-RISE). Quite complicated for someone who had nothing to do with this kind of literature before. Attracted by the breast cancer research topic of NEOSETAC, I decided to apply for that position, and this was the beginning of a big adventure: I spent 5 secondment months in Spain last year.

    Read more

  • Semi-automation of process analytics – the “dish washer” of a bioprocessing lab

    Automation is the future of numerous processes – not only in our everyday life but also in more specialized areas such as bioprocessing. Researchers are eager to find solutions in order to replace routine steps by automated process sections. This gives them the opportunity to spend the gained time on more meaningful things: thinking about new innovations!

    Read more

  • Recycling of protective suits

    We are living in a throwaway society; this is also true for clothes. When we think of the personal protective equipment for work safety such as mechanically robust and fire resistant clothes, it makes sense that they also have an expiration date. But that does not mean that also the ingredients have lost their functionality. Usually, these compounds have been produced with considerable energy effort, thus, it reasonable to find an efficient recycling method.

    Read more

  • The Lump Sum Pilot – virtue or curse?

    A new development in the European framework programs for research and innovation is catching attention: the lump sum pilot. First implementations are in progress already in Horizon 2020 and intensified for the next framework program Horizon Europe. What does it mean for the research community and which changes do we expect?

    Read more

  • When biotechnologists follow their noses

    It is grey, waxy, smelly and very expensive: Ambra, the worlds rarest organic substance, could only be found in the digestive tract of sperm whales. The compound is highly sought after by the perfume industry due to its fragrance fixative properties and distinctive aroma. Biotechnologists found a new biosynthetic pathway to produce the precursor of Ambra, names Ambrein, exactly as it occurs in nature. The findings could revolutionize the perfume industry by making different products eco-friendly.

    Read more

  • How microbiome studies can provide the basis to reduce food waste

    Plants, which are the primary source of food and animal feed, are not only affected by diseases during their growth but also following harvest and subsequent storage. Especially fungi that can efficiently degrade organic matter cause substantial losses of this valuable resource. Such losses can be prevented if adequate countermeasures are implemented. A recent study demonstrates how microbial markers can be used for the early detection of disease progression. Reliable biomarkers can be specifically targeted in the future to reduce food waste and to improve the storability of agricultural goods.

    Read more

  • The orchestra of yeast and its fragrance show

    Enzymes are playing the first violin, the cell is hosting a perfectly coordinated orchestra and reserachers are the composers? Instead of sounds they produce fragrances? Our musical thought experiment demonstrates the complex production processes of biotechnology with aromatics as an example.

    Read more

  • Carbon dioxide in a circular economy

    Carbon dioxide (CO2) emission is a massive problem for our climate; this is well-known. We urgently need measures to prevent earth from the big collapse. Where do we find them? Biotechnology offers some interesting solutions.

    Read more

  • Time for real-time monitoring of biopharma production

    While currently most production processes for biopharmaceuticals are assessed by laboriuos and time-consuming off-line analytics, a new process enables the monitoring of such processes in real-time. Sensors  combined with  mathematical models deliver information on the quality and quantity of the product, as well as on content and profile impurities. This allows an instant monitoring of processes, making processes safer, faster, cheaper and more efficient.

    Read more

COMPANY PROFILE AND OWNERS

acib is an industrially oriented private limited company with a non-profit orientation. It is publicly owned by:

K2 RESEARCH CENTRE

acib is funded as a K2 research centre in the framework of FFG COMET funding (Competence Centres for Excellent Technologies) by BMVIT, BMWF, and the provinces of Styria, Vienna, Lower Austria and Tyrol. The COMET programme is processed via FFG.

More about COMET



Innovations from Nature 1
Innovations from Nature 4
Innovations from Nature 5
Innovations from Nature 2
Innovations from Nature 3
Innovations from Nature 6